Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients

OBJECTIVE: We evaluated the effectiveness of a raltegravir (RAL)-containing regimen plus an optimized background regimen in HIV-1 highly treatment-experienced patients. DESIGN: A retrospective cohort, multicentre study was conducted. METHODS: Adult (>16 years old) HIV treatment-experience patient...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drugs R D
Glavni autori: Mata-Marín, José Antonio, Smeke, Ariane Estrella Weiser, Rodriguez, Mariana Rotzinger, Chávez-García, Marcelino, Banda-Lara, Marco Isaac, Rios, Alma Minerva Pérez, Nuñez-Rodríguez, Nohemí, Domínguez-Hermosillo, Juan Carlos, Sánchez, Alberto Chaparro, Juarez-Kasusky, Irene, Herrera, Javier Enrique Cruz, Ramírez, Jorge Luis Sandoval, Gaytán-Martínez, Jesús
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2017
Teme:
Original Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318342/
https://ncbi.nlm.nih.gov/pubmed/28124232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0174-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items